Search

Your search keyword '"Ogoina, Dimie"' showing total 252 results
Start Over Author "Ogoina, Dimie"
252 results on '"Ogoina, Dimie"'

1. Mpox Epidemiology and Risk Factors, Nigeria, 2022

Author

Ogoina, Dimie, Dalhat, Mahmmod Muazu, Denue, Ballah Akawu, Okowa, Mildred, Chika-Igwenyi, Nneka Marian, Oiwoh, Sebastine Oseghae, Tobin, Ekaete Alice, Yusuff, Hakeem Abiola, Ojimba, Anastacia Okwudili, Christian, Umenzekwe Chukwudi, Aremu, John-Tunde, Gomerep, Simji Samuel, Habila, Kambai Lalus, Awang, Sati Klein, Adekanmbi, Olukemi, Iroezindu, Michael, Onukak, Asukwo, Falodun, Olanrewaju, Sunday, Mogaji, Johnson, Simon Mafuka, Olaitan, Abimbola, Onyeaghala, Chizaram, Alasia, Datonye, Mmerem, Juliet, Unigwe, Uche, Kwaghe, Vivian, and Adeiza, Mukhtar Abdulmajid

Subjects
Human monkeypox -- Diagnosis -- Care and treatment, Medical research, Medicine, Experimental, Prevalence studies (Epidemiology), Health risk assessment -- Evaluation, Health
Abstract

Human mpox is a zoonotic disease caused by 2 distinct clades (I and II) of the monkeypox virus (MPXV) (1). Clade I primarily affects children and adolescents in Central Africa, [...]

Published
2024
Full Text
View/download PDF

2. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study

Author

Ogoina, Dimie, Dalhat, Mahmood Muazu, Denue, Ballah Akawu, Okowa, Mildred, Chika-Igwenyi, Nneka Marian, Yusuff, Hakeem Abiola, Christian, Umenzekwe Chukwudi, Adekanmbi, Olukemi, Ojimba, Anastacia Okwudili, Aremu, John Tunde, Habila, Kambai Lalus, Oiwoh, Sebastine Oseghae, Tobin, Ekaete Alice, Johnson, Simon Mafuka, Olaitan, Abimbola, Onyeaghala, Chizaram, Gomerep, Simji Samuel, Alasia, Datonye, Onukak, Asukwo E, Mmerem, Juliet, Unigwe, Uche, Falodun, Olanrewaju, Kwaghe, Vivian, Awang, Sati Klein, Sunday, Mogaji, Maduka, Chiedozie James, Na'uzo, Aliyu Mamman, Owhin, Sampson Omagbemi, Mohammed, Abdullahi Asara, and Adeiza, Mukhtar Abdulmajid

Published
2023
Full Text
View/download PDF

4. Human monkeypox – After 40 years, an unintended consequence of smallpox eradication

Author

Simpson, Karl, Heymann, David, Brown, Colin S, Edmunds, W John, Elsgaard, Jesper, Fine, Paul, Hochrein, Hubertus, Hoff, Nicole A, Green, Andrew, Ihekweazu, Chikwe, Jones, Terry C, Lule, Swaib, Maclennan, Jane, McCollum, Andrea, Mühlemann, Barbara, Nightingale, Emily, Ogoina, Dimie, Ogunleye, Adesola, Petersen, Brett, Powell, Jacqueline, Quantick, Ollie, Rimoin, Anne W, Ulaeato, David, and Wapling, Andy

Subjects
Medical Microbiology, Biomedical and Clinical Sciences, Infectious Diseases, Vaccine Related, Immunization, Prevention, Emerging Infectious Diseases, Biodefense, Rare Diseases, Small Pox, Infection, Good Health and Well Being, Ghana, Humans, Israel, London, Monkeypox, Monkeypox virus, Nigeria, Singapore, Smallpox, Smallpox Vaccine, Orthopox, Eradication, Risk, Epidemiology, Vaccines, smallpox, monkeypox, orthopox, eradication, Risk, epidemiology, vaccines, Biological Sciences, Agricultural and Veterinary Sciences, Medical and Health Sciences, Virology, Biomedical and clinical sciences, Health sciences
Abstract

Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation of routine smallpox vaccination in most countries. It is estimated that over 70% of the world's population is no longer protected against smallpox, and through cross-immunity, to closely related orthopox viruses such as monkeypox. Monkeypox is now a re-emerging disease. Monkeypox is endemic in as yet unconfirmed animal reservoirs in sub-Saharan Africa, while its human epidemiology appears to be changing. Monkeypox in small animals imported from Ghana as exotic pets was at the origin of an outbreak of human monkeypox in the USA in 2003. Travellers infected in Nigeria were at the origin of monkeypox cases in the UK in 2018 and 2019, Israel in 2018 and Singapore in2019. Together with sporadic reports of human infections with other orthopox viruses, these facts invite speculation that emergent or re-emergent human monkeypox might fill the epidemiological niche vacated by smallpox. An ad-hoc and unofficial group of interested experts met to consider these issues at Chatham House, London in June 2019, in order to review available data and identify monkeypox-related research gaps. Gaps identified by the experts included:The experts further agreed on the need for a better understanding of the genomic evolution and changing epidemiology of orthopox viruses, the usefulness of in-field genomic diagnostics, and the best disease control strategies, including the possibility of vaccination with new generation non-replicating smallpox vaccines and treatment with recently developed antivirals.

Published
2020

5. Mpox in people with advanced HIV infection: a global case series

Author

Leiro, Viviana, Marchetta, Lucila, Fernandez Pardal, Patricia, Figueroa, María Inés, Cahn, Pedro, Grabmeier-Pfistershammer, Katharina, Libois, Agnes, Liesenborghs, Laurens, Grinsztejn, Beatriz, Schechter, Mauro, dos Santos de Lemos, Alberto, Furtado Costa, Alvaro, Queiroz Rocha, Simone, Valdez Madruga, José, S. Tan, Darrell H., Mishra, Sharmistha, Shah, Shreya, Jorquera, Camila, Castillo, Alberto, Carrión, Mauricio, Cevallos, Nelson, Palich, Romain, Pourcher, Valerie, Rubenstein, Emma, Migaud, Pascal, Boesecke, Christoph, Hoffmann, Christian, Protopapas, Konstantinos, Nozza, Silvia, Cattelan, Anna Maria, Mussini, Cristina, d'Arminio Monforte, Antonella, Cruz Flores, Raúl Adrian, Pérez Barragán, Edgar, Rodríguez Guzmán, Alma Leticia, Ogoina, Dimie, Chika-Igwenyi, Nneka Marian, Chizaram, Onyeaghala, Valverde López, Jenny, García Tello, Angelica, Ubals, Maria, Vall, Martí, Mendoza, Adrià, Suñer, Clara, Clotet, Bonaventura, Bechini, Jordi, Lepe, Jose A, Navarro-Amuedo, M. Dolores, Bernadino, Jose Ignacio, Català, Alba, Tarín Vicente, Eloy José, González Rodríguez, Borja, Rodriguez-Mercader, Sergi, Sánchez-Martinez, Francisca, Cañas-Ruano, Esperanza, Parra-Navarro, Laura, Filén, Finn, Tallón de Lara, Carmen, Braun, Dominique, Piezzi, Vanja, Burkhard, Michael, Kovari, Helen, Mönch, Anja, Dunning, Jake, Simoes, Pedro, Nori, Achyuta, Keegan, Sarah, Thornhill, John P, Apea, Vanessa, Noori, Teymur, Jones, Joyce L., Judson, Seth, Gilliams, Elizabeth A., Hamill, Matthew M., Keruly, Jeanne, Henao Martínez, Andrés F., Lin, Aung, So, Jessica, Davar, Kusha, Villareal, Diana, Tapia Paredes, Miguel, Mitjà, Oriol, Alemany, Andrea, Marks, Michael, Lezama Mora, Jezer I, Rodríguez-Aldama, Juan Carlos, Torres Silva, Mayara Secco, Corral Herrera, Ever Arturo, Crabtree-Ramirez, Brenda, Blanco, José Luis, Girometti, Nicolo, Mazzotta, Valentina, Hazra, Aniruddha, Silva, Macarena, Montenegro-Idrogo, Juan José, Gebo, Kelly, Ghosn, Jade, Peña Vázquez, María Fernanda, Matos Prado, Eduardo, Unigwe, Uche, Villar-García, Judit, Wald-Dickler, Noah, Zucker, Jason, Paredes, Roger, Calmy, Alexandra, Waters, Laura, Galvan-Casas, Cristina, Walmsley, Sharon, and Orkin, Chloe M

Published
2023
Full Text
View/download PDF

6. Monkeypox

Author

Mitjà, Oriol, Ogoina, Dimie, Titanji, Boghuma K, Galvan, Cristina, Muyembe, Jean-Jacques, Marks, Michael, and Orkin, Chloe M

Published
2023
Full Text
View/download PDF

8. Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series

Author

Thornhill, John P, Palich, Romain, Ghosn, Jade, Walmsley, Sharon, Moschese, Davide, Cortes, Claudia P, Galliez, Rafael Mello, Garlin, Amy B, Nozza, Silvia, Mitja, Oriol, Radix, Asa E, Blanco, Jose Luis, Crabtree-Ramirez, Brenda, Thompson, Melanie, Wiese, Lothar, Schulbin, Hubert, Levcovich, Ariela, Falcone, Marco, Lucchini, Anna, Sendagorta, Elena, Treutiger, Carl-Johan, Byrne, Ruth, Coyne, Katherine, Meyerowitz, Eric A, Grahn, Anna M, Hansen, Ann-Brit Eg, Pourcher, Valerie, DellaPiazza, Michelle, Lee, Rachel, Stoeckle, Marcel, Hazra, Aniruddha, Apea, Vanessa, Rubenstein, Emma, Jones, Joyce, Wilkin, Aimee, Ganesan, Anuradha, Henao-Martínez, Andrés F, Chow, Eric J, Titanji, Boghuma K, Zucker, Jason E, Ogoina, Dimie, and Orkin, Chloe M

Published
2022
Full Text
View/download PDF

12. Mpox virus and transmission through sexual contact: Defining the research agenda

Author

Low, Nicola, Bachmann, Laura H., Ogoina, Dimie, McDonald, Robert, Ipekci, Aziz Mert, Quilter, Laura A. S., and Cevik, Muge

Subjects
Human monkeypox -- Distribution -- Risk factors -- Demographic aspects, Gay men -- Sexual behavior -- Health aspects, MSM (Men who have sex with men) -- Health aspects, Company distribution practices, Biological sciences
Abstract

Author(s): Nicola Low 1,*, Laura H. Bachmann 2, Dimie Ogoina 3, Robert McDonald 2, Aziz Mert Ipekci 1,4, Laura A. S. Quilter 2, Muge Cevik 5 Summary points A multicountry [...]

Published
2023
Full Text
View/download PDF

13. Intersecting HIV and mpox epidemics: more questions than answers

Author

Girometti, Nicolo, Ogoina, Dimie, Tan, Darrell H.S., Pozniak, Anton, and Klein, Marina B.

Subjects
Human monkeypox -- Diagnosis -- Care and treatment, HIV (Viruses) -- Diagnosis -- Care and treatment, Epidemics -- Control -- Nigeria, Health
Abstract

Mpox was declared a Public Health Emergency of International Concern by the World Health Organization on 23 July 2022 [1], following a rapid increase in cases beginning in Europe in [...]

Published
2022
Full Text
View/download PDF

14. Predictors of antibiotic prescriptions: a knowledge, attitude and practice survey among physicians in tertiary hospitals in Nigeria

Author

Ogoina, Dimie, Iliyasu, Garba, Kwaghe, Vivian, Otu, Akan, Akase, Iorhen Ephram, Adekanmbi, Olukemi, Mahmood, Dalhat, Iroezindu, Micheal, Aliyu, Shamsudin, Oyeyemi, Abisoye Sunday, Rotifa, Stella, Adeiza, Mukhtar Abdulmajid, Unigwe, Uche Sonny, Mmerem, Juliet Ijeoma, Dayyab, Farouq Muhammad, Habib, Zaiyad Garba, Otokpa, Daniel, Effa, Emmanuel, and Habib, Abdulrazaq Garba

Published
2021
Full Text
View/download PDF

16. Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report

Author

Mandra, Anna, Davidson, Whitni, Olson, Victoria, Li, Yu, Radford, Kay, Zhao, Hui, Townsend, Michael, Burgado, Jillybeth, Satheshkumar, Panayampalli S., Yinka-Ogunleye, Adesola, Aruna, Olusola, Dalhat, Mahmood, Ogoina, Dimie, McCollum, Andrea, Disu, Yahyah, Mamadu, Ibrahim, Akinpelu, Afolabi, Ahmad, Adama, Burga, Joel, Ndoreraho, Adolphe, Nkunzimana, Edouard, Manneh, Lamin, Mohammed, Amina, Adeoye, Olawunmi, Tom-Aba, Daniel, Silenou, Bernard, Ipadeola, Oladipupo, Saleh, Muhammad, Adeyemo, Ayodele, Nwadiutor, Ifeoma, Aworabhi, Neni, Uke, Patience, John, Doris, Wakama, Paul, Reynolds, Mary, Mauldin, Matthew R, Doty, Jeffrey, Wilkins, Kimberly, Musa, Joy, Khalakdina, Asheena, Adedeji, Adebayo, Mba, Nwando, Ojo, Olubunmi, Krause, Gerard, and Ihekweazu, Chikwe

Published
2019
Full Text
View/download PDF

18. The surge of mpox in Africa: a call for action

Author

Nachega, Jean B, Sam-Agudu, Nadia A, Ogoina, Dimie, Mbala-Kingebeni, Placide, Ntoumi, Francine, Nakouné, Emmanuel, Njouom, Richard, Lewis, Rosamund F, Gandhi, Monica, Rosenthal, Philip J, Rawat, Angeli, Wilson, Lindsay A, Kindrachuk, Jason, Liesenborghs, Laurens, Mills, Edward J, Preiser, Wolfgang, Rimoin, Anne W, Sullivan, Nancy J, Peeters, Martine, Delaporte, Eric, Baxter, Cheryl, Harrison, Lee, Hermans, Michel P, Mohr, Emma L, Gonsalves, Gregg, Ndembi, Nicaise, Zumla, Alimuddin, and Muyembe-Tamfum, Jean Jacques

Published
2024
Full Text
View/download PDF

24. Mpox in pregnancy: Management, risks and challenges in Africa and lessons from the COVID ‐19 pandemic

Author

Ubom, Akaninyene Eseme, primary, Oiwoh, Sebastine Oseghae, additional, Ajiboye, Akinyosoye Deji, additional, Nyeche, Solomon, additional, Appiah‐Kubi, Adu, additional, Sokunbi, Aisha Ebehireme, additional, Mbiiza, Christabel Mweene, additional, Olanrewaju, Fatai Olatunde, additional, Ighorodje, Edesiri Ejovwoke, additional, Akinkugbe, Ayesha, additional, Okoeguale, Joseph, additional, Ojo, Oluwaseun Dorcas, additional, Unwaha, Emmanuel Adeiza, additional, Oriji, Peter Chibuzor, additional, Adebawojo, Tolulope Oluwatimileyin, additional, Ekwebalam, Obinna Prince, additional, Okwaraoha, Treasure Inyeneobong, additional, Ijarotimi, Omotade Adebimpe, additional, Eifediyi, Reuben Agbons, additional, Okogbenin, Sylvanus Akhalufo, additional, Okwor, Tochi, additional, Ikimalo, John Igemo, additional, Kuti, Oluwafemi, additional, Fasubaa, Olusola Benjamin, additional, and Ogoina, Dimie, additional

Published
2023
Full Text
View/download PDF

25. Clinical profile and predictors of outcomes of hospitalized patients with laboratory-confirmed severe acute respiratory syndrome Coronavirus 2 in Nigeria: A retrospective analysis of 13 high burden states in Nigeria

Author

Yilgwan, Christopher Sabo, Onu, Adamu, Ofoli, Joshua, Dakum, Longji Benle, Shehu, Nathan Yakubu, Ogoina, Dimie, Okoli, Ijeoma, Osisanwo, Deborah, Okafor, Vivian, Olayinka, Adebola, Mamadu, Ibrahim, and Adebiyi, Adebimpe

Subjects
Clinical Profile, Predictors of Outcomes, Hospitalized Patients, SARS-CoV-2, COVID-19, High Burden States, Nigeria
Abstract

Background: The majority of global COVID deaths have occurred in developed countries. Not much is known about the clinical outcomes for the patients admitted with COVID in Nigeria. We thus described the clinical characteristics, outcomes, and predictors of outcomes of hospitalized Nigerian COVID-19 patients. Methodology: We performed multilevel and mixed effects regression, Kaplan-Meir survival, and Cox proportionate hazards analyses to evaluate factors associated with death in patients admitted for COVID-19 in 13 high-burden states of Nigeria between 25th February 2020 and 30th August 2021. Results: Of the 3462 patients (median age, 40 years (interquartile range 28 years 54 years), 2,990(60.6%) were male and, 213(6.15%) of them died while on admission. Male sex (adjusted odds ratio [aOR], 1.78 [95% confidence interval {CI}, 1.23–2.56]), age group 45-65 years (OR, 3.93 [95% CI, 1.29–12.02]), age group 66-75 years (aOR, 5.37 [95% CI, 1.68–17.14]), age group > 75 years (aOR, 6.81 [95% CI, 2.04– 22.82]), chronic cardiac disease (aOR, 3.07 [95% CI, 1.20–7.86]), being diabetic (aOR, 2.16 [95% CI, 1.41– 3.31]), and having chronic kidney disease (OR, 11.01 [95% CI, 2.74–44.24]),were strongly associated with increased odds of death. Having concurrent malaria (aOR, 0.45 [95% CI, 0.16–1.28]), use of Azithromycin for treatment (aOR, 0.33 [95% CI, 0.19–0.54]), and use of Chloroquine/Hydroxychloroquine for treatment (aOR, 0.07 [95% CI, 0.03–0.14]) were significantly associated with decreased odds of death. Conclusions: The cumulative probability of death of male patients, diabetics, hypertensives, and patients with CKD was higher than that of female patients and those without those comorbidities while concurrent malaria and use of chloroquine/hydroxychloroquine in the treatment regimen were associated with a decreased risk of dying in patients treated in our isolation centers.

Published
2023

26. Mpox in people with advanced HIV infection: a global case series

Author

Mitjà, Oriol, primary, Alemany, Andrea, additional, Marks, Michael, additional, Lezama Mora, Jezer I, additional, Rodríguez-Aldama, Juan Carlos, additional, Torres Silva, Mayara Secco, additional, Corral Herrera, Ever Arturo, additional, Crabtree-Ramirez, Brenda, additional, Blanco, José Luis, additional, Girometti, Nicolo, additional, Mazzotta, Valentina, additional, Hazra, Aniruddha, additional, Silva, Macarena, additional, Montenegro-Idrogo, Juan José, additional, Gebo, Kelly, additional, Ghosn, Jade, additional, Peña Vázquez, María Fernanda, additional, Matos Prado, Eduardo, additional, Unigwe, Uche, additional, Villar-García, Judit, additional, Wald-Dickler, Noah, additional, Zucker, Jason, additional, Paredes, Roger, additional, Calmy, Alexandra, additional, Waters, Laura, additional, Galvan-Casas, Cristina, additional, Walmsley, Sharon, additional, Orkin, Chloe M, additional, Leiro, Viviana, additional, Marchetta, Lucila, additional, Fernandez Pardal, Patricia, additional, Figueroa, María Inés, additional, Cahn, Pedro, additional, Grabmeier-Pfistershammer, Katharina, additional, Libois, Agnes, additional, Liesenborghs, Laurens, additional, Grinsztejn, Beatriz, additional, Schechter, Mauro, additional, dos Santos de Lemos, Alberto, additional, Furtado Costa, Alvaro, additional, Queiroz Rocha, Simone, additional, Valdez Madruga, José, additional, S. Tan, Darrell H., additional, Mishra, Sharmistha, additional, Shah, Shreya, additional, Jorquera, Camila, additional, Castillo, Alberto, additional, Carrión, Mauricio, additional, Cevallos, Nelson, additional, Palich, Romain, additional, Pourcher, Valerie, additional, Rubenstein, Emma, additional, Migaud, Pascal, additional, Boesecke, Christoph, additional, Hoffmann, Christian, additional, Protopapas, Konstantinos, additional, Nozza, Silvia, additional, Cattelan, Anna Maria, additional, Mussini, Cristina, additional, d'Arminio Monforte, Antonella, additional, Cruz Flores, Raúl Adrian, additional, Pérez Barragán, Edgar, additional, Rodríguez Guzmán, Alma Leticia, additional, Ogoina, Dimie, additional, Chika-Igwenyi, Nneka Marian, additional, Chizaram, Onyeaghala, additional, Valverde López, Jenny, additional, García Tello, Angelica, additional, Ubals, Maria, additional, Vall, Martí, additional, Mendoza, Adrià, additional, Suñer, Clara, additional, Clotet, Bonaventura, additional, Bechini, Jordi, additional, Lepe, Jose A, additional, Navarro-Amuedo, M. Dolores, additional, Bernadino, Jose Ignacio, additional, Català, Alba, additional, Tarín Vicente, Eloy José, additional, González Rodríguez, Borja, additional, Rodriguez-Mercader, Sergi, additional, Sánchez-Martinez, Francisca, additional, Cañas-Ruano, Esperanza, additional, Parra-Navarro, Laura, additional, Filén, Finn, additional, Tallón de Lara, Carmen, additional, Braun, Dominique, additional, Piezzi, Vanja, additional, Burkhard, Michael, additional, Kovari, Helen, additional, Mönch, Anja, additional, Dunning, Jake, additional, Simoes, Pedro, additional, Nori, Achyuta, additional, Keegan, Sarah, additional, Thornhill, John P, additional, Apea, Vanessa, additional, Noori, Teymur, additional, Jones, Joyce L., additional, Judson, Seth, additional, Gilliams, Elizabeth A., additional, Hammill, Matthew, additional, Keruly, Jeanne, additional, Henao Martínez, Andrés F., additional, Lin, Aung, additional, So, Jessica, additional, Davar, Kusha, additional, and Villareal, Diana, additional

Published
2023
Full Text
View/download PDF

30. Reemergence of Human Monkeypox in Nigeria, 2017

Author

Yinka-Ogunleye, Adesola, Aruna, Olusola, Ogoina, Dimie, Aworabhi, Neni, Eteng, Womi, Badaru, Sikiru, Mohammed, Amina, Agenyi, Jeremiah, Etebu, E.N., Numbere, Tamuno-Wari, Ndoreraho, Adolphe, Nkunzimana, Eduard, Disu, Yahyah, Dalhat, Mahmood, Nguku, Patrick, Mohammed, Abdulaziz, Saleh, Muhammad, McCollum, Andrea, Wilkins, Kimberly, Faye, Ousmane, Sall, Amadou, Happi, Christian, Mba, Nwando, Ojo, Olubumi, and Ihekweazu, Chikwe

Subjects
Human monkeypox -- Health aspects, Zoonoses -- Health aspects, Disease transmission -- Health aspects, Health
Abstract

Human monkeypox is a rare zoonotic infection caused by an orthopoxvirus and characterized by smallpox-like signs and symptoms (1). The disease is endemic to the Democratic Republic of the Congo. [...]

Published
2018
Full Text
View/download PDF

39. Human Monkeypox Virus Infection in Women During the 2022 Outbreaks – a Global Case Series

Author

Thornhill, John Patrick, primary, Palich, Romain, additional, Ghosn, Jade, additional, Walmsley, Sharon, additional, Moschese, Davide, additional, Cortes, Claudia P., additional, Galliez, Rafael M., additional, Garlin, Amy B., additional, Nozza, Silvia, additional, Mitja, Oriol, additional, Radix, Asa E., additional, Blanco, Jose, additional, Crabtree-Ramirez, Brenda, additional, Thompson, Melanie, additional, Wiese, Lothar, additional, Schulbin, Hubert, additional, Levocvich, Ariela, additional, Falcone, Marco, additional, Lucchini, Anna, additional, Sendagorta, Elena, additional, Treutiger, Carl Johan, additional, Byrne, Ruth, additional, Coyne, Katherine, additional, Meyerowitz, Eric A., additional, Grahn, Anna M., additional, Eg.Hansen, Ann-Brit, additional, Pourcher, Valérie, additional, Piazza, Michelle Dalla, additional, Lee, Rachel, additional, Stoeckle, Marcel, additional, Hazra, Aniruddha, additional, Apea, Vanessa, additional, Rubenstein, Emma, additional, Jones, Joyce, additional, Wilkin, Aimee, additional, Ganesan, Anuradha, additional, Henao-Martínez, Andrés, additional, Chow, Eric J., additional, Titanji, Boghuma K., additional, Zucker, Jason, additional, Ogoina, Dimie, additional, Orkin, Chloe, additional, and Group, SHARE NET Writing, additional

Published
2022
Full Text
View/download PDF

44. A national survey of hospital readiness during the COVID-19 pandemic in Nigeria

Author

Ogoina, Dimie, primary, Mahmood, Dalhat, additional, Oyeyemi, Abisoye Sunday, additional, Okoye, Ogochukwu Chinedum, additional, Kwaghe, Vivian, additional, Habib, Zayaid, additional, Unigwe, Uche, additional, Iroezindu, Michael Onyebuchi, additional, Garbati, Musa Abubakar, additional, Rotifa, Stella, additional, Adekanmbi, Olukemi, additional, Garba, Iliyasu, additional, Dayyab, Farouq Muhammad, additional, Ibrahim, Sanusi Mohammed, additional, Kida, Ibrahim Musa, additional, Adamu, Adamu, additional, Alasia, Datonye, additional, Awang, Sati Klein, additional, Ohaju-Obodo, John Oghenevwirhe, additional, Usman, Rabi, additional, Mohammed, Yahaya, additional, Omololu, Ayanfe, additional, Tobin, Ekaete Alice, additional, Okogbenin, Sylvanus, additional, Asogun, Danny, additional, Kelly, Iraoyah, additional, Waziri, Bala, additional, Nauzo, Aliyu Mamman, additional, Jibrin, Yusuf, additional, and Habib, Abdulrazaq Garba, additional

Published
2021
Full Text
View/download PDF

46. Bayelsa Health Summit: strategizing for health at a subnational level in Nigeria.

Author

Ogoina, Dimie, Kaduru, Chijioke, Stow, Jones, Okoyen, Ebikapaye, and Igwele, Pabara N

Subjects
SUBNATIONAL governments, STRATEGIC planning, STAKEHOLDER analysis, STATE governments, STATE laws
Abstract

Nigeria is falling short of global targets for universal health coverage (UHC) and the country's journey toward the accelerated achievement of UHC is dependent on progress made by all its subnational governments. The Bayelsa State Health Summit (BSHS) was organized by a subnational government in the Niger Delta region of Nigeria to deepen the understanding of the state's health system and to strategize for improved health outcomes. In this article we share our experience with the planning, organization and outcomes of the BSHS. The BSHS titled 'Achieving Improved Health Systems Performance through Strategic Planning and Stakeholder Engagement' was held for 3 d in April 2021. More than 1800 participants across diverse national and international organizations deliberated and made recommendations across the summit theme and subthemes. At the end of the summit, the state government and summit participants resolved to enact a state health law, to develop and adopt a state 10-y health system improvement plan and to establish a Bayelsa Centre for Disease Control. The BSHS exposed the context-specific needs, challenges and expectations of the Bayelsa health system. It served as a platform for extensive stakeholder engagement and buy-in and fostered high-level political commitment for the transformation of the Bayelsa health system. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

47. Leptin concentrations in type 2 diabetes and non-diabetes Nigerian-Africans

Author

Onyemelukwe, Obiageli Uzoamaka, Ogoina, Dimie, and Onyemelukwe, Geoffrey Chukwubuike

Subjects
Original Article
Abstract

Most studies on leptin in diabetes mellitus (DM) compared to healthy controls were done in Caucasians, with conflicting findings. Paucity of data on this exists in Nigerian-Africans. Therefore, the study determined plasma leptin concentrations in newly diagnosed type-2 diabetes versus controls and its relation to obesity/demographic-metabolic indices. A cross-sectional comparative study on 154 subjects: 67 diabetes and 87 healthy controls at the Ahmadu Bello University Teaching Hospital, Nigeria. Leptin was determined by the sandwich enzyme-linked immunosorbent assay. Mann-Whitney U test, Spearman’s Correlation and Step-wise Multiple Logistic Regression analysis of Log-transformed variables determined outcomes. Leptin trended towards lower levels in DM subjects than controls when both sexes were combined, though insignificant (P=0.12). Leptin was significantly (P0.05) correlation to fasting insulin (FI) and HOMA-IR. WC was an independent predictor of Ln(10)hyperleptinaemia in DM subjects (OR: 1.12, 95% CI, 1.03-1.23, P=0.01). BMI showed significant (P

Published
2020

48. Leptin Concentrations in Non-Obese and Obese Non-Diabetes Nigerian-Africans

Author

Agbogu-Ike,Obiageli Uzoamaka, Ogoina,Dimie, Onyemelukwe,Geoffrey Chukwubuike, Agbogu-Ike,Obiageli Uzoamaka, Ogoina,Dimie, and Onyemelukwe,Geoffrey Chukwubuike

Abstract

Obiageli Uzoamaka Agbogu-Ike,1 Dimie Ogoina,2 Geoffrey Chukwubuike Onyemelukwe1 1Department of Medicine, Ahmadu Bello University (ABU) Teaching Hospital, Zaria, Nigeria; 2Department of Medicine, Niger Delta University Teaching Hospital, Okolobiri, Bayelsa, NigeriaCorrespondence: Obiageli Uzoamaka Agbogu-IkeDepartment of Medicine, ABUTH, Zaria, NigeriaTel +234 8129930000Email obiageliuo629@gmail.comBackground: Controversial findings exist on the role of leptin in obesity and its correlation with metabolic variables, with few data emanating from Nigerian-Africans. Plasma leptin was therefore determined in obese and non-obese. Its relationship with obesity indices and metabolic variables were further envisaged.Materials and Methods: A cross-sectional comparative study on 87 randomly-selected non-diabetes Nigerians distributed into 3 groups (24 normal, 23 pre-obese and 40 obese). Obesity indices, fasting Insulin (FI) and homeostasis model assessment-insulin resistance (HOMA-IR) were determined. Plasma leptin was determined by sandwich enzyme-linked immunosorbent assay. Mann-Whitney U-test, Independent Kruskal-Wallis test, Spearman correlation and Step-wise Multivariate Logistic Regression analysis determined outcomes.Results: Median+IQR leptin concentrations were higher in obese {61.8(40.8, 91.4) ng/mL, p< 0.001} than pre-obese {42.7(28.0, 51.7) ng/mL, p=0.003} and normal {28.6(20.7, 39.8) ng/mL, p=0.03} BMI categories. Leptin was higher (p< 0.001) in females than males {Median+IQR, 52.0 (35.0, 80.0) ng/mL versus 34.0(24, 65.0 ng/mL)}. Leptin was positively correlated with body fat percentage (BFP), r=0.57; waist circumference (WC), r=0.46 and body mass index (BMI), r=0.50, p< 0.001, respectively in all subjects, with higher correlation coefficient in males than females. Leptin showed sex-specific correlations to age, FI and HOMA-IR. In the unadjusted models, central obesity/generalized obesity, WC, BMI, BFP, combined pre-obesity/obesity, younger age and female

Published
2021

49. Predictors of antibiotic prescriptions: a knowledge, attitude and practice survey among physicians in tertiary hospitals in Nigeria

Author

Ogoina, Dimie, primary, Iliyasu, Garba, additional, Kwaghe, Vivian, additional, Otu, Akan, additional, Akase, Iorhen Ephram, additional, Adekanmbi, Olukemi, additional, Dalhat, Mahmmod, additional, Iroezindu, Micheal, additional, Aliyu, Shamsudin, additional, Oyeyemi, Abisoye Sunday, additional, Rotifa, Stella, additional, Adeiza, Mukhtar Abdulmajid, additional, Unigwe, Uche Sonny, additional, Mmerem, Juliet Ijeoma, additional, Dayyab, Farouq Muhammad, additional, Habib, Zaiyad Garba, additional, Otokpa, Daniel, additional, Effa, Emmanuel, additional, and Habib, Abdulrazaq Garba, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results